Redefining the Value of Diagnostics in a Changing Payment Environment

 

Redefining the Value of Diagnostics in a Changing Payment Environment

Please join Charles Mathews, Vice President, Boston Healthcare Associates, as he shares insights into how laboratorians can better frame the value of the testing services they provide to payers and hospital administration along with identifying tools to secure value-based funds for testing.

 

Previous Article
Assessing the Financial Impact of Your DMT
Assessing the Financial Impact of Your DMT

Measure the value of your Diagnostic Management Team by quantifying its financial impact on your organization

Next Article
Generating Revenue for Your Organization Through DMT Interpretations
Generating Revenue for Your Organization Through DMT Interpretations

Demonstrate the value of your DMT by generating revenue and results for your organization

×

LabLeaders.com has a new home. Tell us a bit about yourself.

First Name
Last Name
Mobile Phone Number
Thank you!
Error - something went wrong!